Lexaria Bioscience (LEXX) Change in Receivables (2010 - 2026)
Lexaria Bioscience's Change in Receivables was $6,969 in fiscal Q3 2026 (quarter ended May 31, 2026), down 74.2% from $26,964 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Change in Receivables (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexaria Bioscience's Change in Receivables was -$309,131 through May 31, 2026; for FY2025 (ended Aug 31, 2025), it was $213,881, up 501.6% from FY2024.
- In earlier fiscal years, Change in Receivables was $35,551 in FY2024, -$26,539 in FY2023, -$137,491 in FY2022 and -$189,580 in FY2021.
- Quarterly Change in Receivables has moved between -$280,314 (fiscal Q1 2026) and $408,045 (fiscal Q1 2024) over five years.
- Per Business Quant data, LEXX's Change in Receivables in the three fiscal quarters before Q3 2026 was -$46,015 (Q2 2026), -$280,314 (Q1 2026) and $10,229 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | 6,969.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 6,969.00 |
| Feb 28, 2026 | -46,015.00 |
| Nov 30, 2025 | -280,314.00 |
| Aug 31, 2025 | 10,229.00 |
| May 31, 2025 | 26,964.00 |
| Feb 28, 2025 | 67,674.00 |
| Nov 30, 2024 | 109,014.00 |
| Aug 31, 2024 | -46,208.00 |
| May 31, 2024 | -148,645.00 |
| Feb 29, 2024 | -177,641.00 |
| Nov 30, 2023 | 408,045.00 |
| Aug 31, 2023 | 2,961.00 |
| May 31, 2023 | -94,488.00 |
| Feb 28, 2023 | -19,550.00 |
| Nov 30, 2022 | 84,538.00 |
| Aug 31, 2022 | -46,917.00 |
| May 31, 2022 | -254,795.00 |
| Feb 28, 2022 | 45,110.00 |
| Nov 30, 2021 | 119,111.00 |
| Aug 31, 2021 | -190,686.00 |
API Access
Lexaria Bioscience Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();